• Overview
  • Eligibility
  • More info
  • Locations

Placebo-controlled, Double-blind, Randomized Study of Aerucin® as Adjunct Therapy to Antibiotics in the Treatment of P. Aeruginosa Pneumonia (NCT03027609)

Prospective, double-blind, randomized assessment of the efficacy, safety and pharmacokinetic of Aerucin® as adjunct treatment (in addition to standard of care antibiotics) for pneumonia caused by P. aeruginosa.
  • Drug: aerubumab
    monoclonal antibody
    • AR-105
    • Aerucin
  • Drug: placebo
    matching placebo
    Ages eligible for Study
    18 Years and older
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    No

    3 locations

    United States (3)
    • Research Site
      recruiting
      Jacksonville, Florida, United States, 32209
    • Research Site
      recruiting
      Saint Louis, Missouri, United States, 63110
    • Research Site
      recruiting
      Columbus, Ohio, United States, 43215
    Status:
    recruiting
    Type:
    Interventional
    Phase:
    Start:
    28 March, 2017
    Updated:
    01 May, 2017
    Participants:
    108
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!